Morpholino

MO2-ptgs1

ID

ZDB-MRPHLNO-050722-4

Name

MO2-ptgs1

Previous Names

Target

Sequence

5' - AACAACAACGTCTTCAAAAGTGGTG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

designed against 5' UTR

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-ptgs1

No data available

Phenotype

Phenotype resulting from MO2-ptgs1

No data available

Phenotype of all Fish created by or utilizing MO2-ptgs1

Phenotype	Fish	Conditions	Figures
exocrine pancreas prss1 expression decreased distribution, abnormal	WT + MO1-ptgs1 + MO2-ptgs1	control	Fig. 2 from Nissim et al., 2014
exocrine pancreas size, ameliorated	WT + MO1-ptgs1 + MO2-ptgs1	chemical treatment: prostaglandin E2	Fig. 2 from Nissim et al., 2014
hematopoietic stem cell decreased amount, abnormal	WT + MO1-ptgs1 + MO2-ptgs1	standard conditions	Fig. S1 from North et al., 2007
exocrine pancreas prss1 expression amount, ameliorated	WT + MO1-ptgs1 + MO2-ptgs1	chemical treatment: prostaglandin E2	Fig. 2 from Nissim et al., 2014
exocrine pancreas decreased size, abnormal	WT + MO1-ptgs1 + MO2-ptgs1	control	Fig. 2 from Nissim et al., 2014
liver EGFP expression decreased distribution, abnormal	as3Tg + MO1-ptgs1 + MO2-ptgs1	control	Fig. 1 from Nissim et al., 2014
liver decreased size, abnormal	as3Tg + MO1-ptgs1 + MO2-ptgs1	control	Fig. 1 from Nissim et al., 2014
liver EGFP expression amount, ameliorated	as3Tg + MO1-ptgs1 + MO2-ptgs1	chemical treatment: prostaglandin E2	Fig. 1 from Nissim et al., 2014
liver size, ameliorated	as3Tg + MO1-ptgs1 + MO2-ptgs1	chemical treatment: prostaglandin E2	Fig. 1 from Nissim et al., 2014
exocrine pancreas decreased size, abnormal	zf578Tg + MO1-ptgs1 + MO2-ptgs1	control	Fig. 2 from Nissim et al., 2014
exocrine pancreas size, ameliorated	zf578Tg + MO1-ptgs1 + MO2-ptgs1	chemical treatment: prostaglandin E2	Fig. 2 from Nissim et al., 2014

Citations